stockportfolio.pro
The Chemours Company Free Cash Flow 2013–2025
The Chemours Company (CC) annual free cash flow by fiscal year, computed from SEC filings. Compound growth -15.0%/yr over 12 years.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $51.00M | +105.1% |
| FY 2024 | $-993.00M | -633.9% |
| FY 2023 | $186.00M | -58.5% |
| FY 2022 | $448.00M | -16.6% |
| FY 2021 | $537.00M | -0.6% |
| FY 2020 | $540.00M | +219.5% |
| FY 2019 | $169.00M | -73.7% |
| FY 2018 | $642.00M | +180.3% |
| FY 2017 | $229.00M | -10.5% |
| FY 2016 | $256.00M | +176.0% |
| FY 2015 | $-337.00M | -240.4% |
| FY 2014 | $-99.00M | -127.5% |
| FY 2013 | $360.00M | — |
Source: The Chemours Company SEC filings — cash flow statement (10-K). Refreshed nightly.
See the full picture for The Chemours Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeThe Chemours Company — frequently asked questions
What is The Chemours Company's free cash flow?
The Chemours Company (CC) reported free cash flow of $51.00M for fiscal year 2025, per its SEC filings.
How has The Chemours Company's free cash flow changed over time?
Between fiscal 2013 and 2025, CC's free cash flow declined at roughly 15.0% per year (compound annual rate), from $360.00M to $51.00M.
Where does this data come from?
Figures are computed from The Chemours Company's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.